Seqens Seqens

X

Find the latest news about Neuraptive Therapeutics aggregated by PharmaCompass.com.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Neuraptive Therapeutics
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
2 Logan Square Suite 1930 Philadelphia, PA 19103
Telephone
Telephone
+1.617.794.6442
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.businesswire.com/news/home/20240222942067/en

BUSINESSWIRE
22 Feb 2024

https://www.businesswire.com/news/home/20240115132196/en

BUSINESSWIRE
15 Jan 2024

https://www.businesswire.com/news/home/20240108340125/en

BUSINESSWIRE
08 Jan 2024

https://www.businesswire.com/news/home/20230227005033/en

BUSINESSWIRE
27 Feb 2023

https://www.businesswire.com/news/home/20221117005443/en/Neuraptive-Therapeutics-Inc.-Announces-Appointment-of-Leading-Industry-Executive-Dr.-Robert-R.-Ruffolo-as-New-Director-to-the-Board

BUSINESSWIRE
17 Nov 2022

https://www.businesswire.com/news/home/20221117005443/en

BUSINESSWIRE
17 Nov 2022

https://www.businesswire.com/news/home/20221024005766/en

BUSINESSWIRE
24 Oct 2022

https://www.biospace.com/article/releases/neuraptive-therapeutics-announces-first-patient-enrolled-in-a-phase-2-trial-of-ntx-001-for-the-prevention-of-facial-paralysis-and-provides-update-on-the-phase-2-study-of-ntx-001-in-peripheral-nerve-injuries-due-to-trauma/

BIOSPACE
21 Jul 2022

https://www.businesswire.com/news/home/20220721005743/en/Neuraptive-Therapeutics-Announces-First-Patient-Enrolled-in-a-Phase-2-Trial-of-NTX-001-for-the-Prevention-of-Facial-Paralysis-and-Provides-Update-on-the-Phase-2-Study-of-NTX-001-in-Peripheral-Nerve-Injuries-due-to-Trauma

BUSINESSWIRE
21 Jul 2022

https://www.businesswire.com/news/home/20210413005487/en

BUSINESSWIRE
13 Apr 2021
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY